CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-16 | Fardis Maria President and CEO | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2016-06-10 | Henderson Molly CFO | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2016-06-01 | Henderson Molly CFO | Grant or award · Stock Option | +150,000 | 150,000 | ||
| 2016-06-01 | Fardis Maria President & CEO | Grant or award | +550,000 | 550,000 | ||
| 2016-06-01 | Fardis Maria President & CEO | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2016-03-28 | Lotze Michael Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2016-03-11 | HAWKINS ELMA President & CEO | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2016-03-11 | Henderson Molly Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2016-03-11 | Bender James G. Vice President - Manufacturing | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2016-02-04 | Fischkoff Steven A. Chief Medical Officer | Grant or award · Stock Option | +225,000 | 225,000 | ||
| 2015-12-28 | HAWKINS ELMA President and CEO | Grant or award · Stock Option (right to buy) | +58,939 | 58,939 | ||
| 2015-12-28 | Henderson Molly Chief Financial Officer | Grant or award · Stock Option (right to buy) | +21,116 | 21,116 | ||
| 2015-12-28 | Bender James G. Vice President, Manufacturing | Grant or award · Stock Option (right to buy) | +27,622 | 27,622 | ||
| 2015-09-30 | Bender James G. Vice President, Manufacturing | Shares withheld for taxes | −11,274 | $5.76 | $65K | 88,726 |
| 2015-09-08 | Hillsberg Sanford Director | Sale | −16,500 | $7.13 | $118K | 154,000 |
| 2015-09-04 | Hillsberg Sanford Director | Sale | −16,000 | $6.84 | $109K | 170,500 |
| 2015-08-03 | Hillsberg Sanford Director | Sale | −32,500 | $8.15 | $265K | 186,500 |
| 2015-06-12 | Maynard Ryan D Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2015-06-12 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2015-06-12 | MCPEAK MERRILL A Director | Grant or award · Common Stock | +35,000 | 35,000 |
Page 27 of 31 · 605 trades